Pfizer Inc.
Pharmaceuticals & BiotechnologyFounded 1849- Updated June 2026
Reviewed by Swet Parvadiya
Last reviewed: June 2026
CorpDigest
Pfizer Inc.
Annual Revenue
Last reviewed: 2026-06-03 · By Swet Parvadiya
FY2023 Revenue
$58.5B
▼ 41.7% vs FY2022 ($100.3B)
Pfizer Inc. reported $58.5B in revenue for fiscal year 2023. This represents a decline of 41.7% compared to the 2022 figure of $100.3B. In 2024, revenue increased to $63.6B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $63.6B | $8.0B | +8.7% |
| FY2023 | $58.5B | — | -41.7% |
| FY2022 | $100.3B | — | +23.4% |
| FY2021 | $81.3B | — | +94.0% |
| FY2020 | $41.9B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.